NFKB1 is distributed among several pathways in Module 4 involving the MAPK signaling pathway, chronic myeloid leukemia, pancreatic cancer, the Toll-like receptor signaling pathway, acute myeloid leukemia, T-cell and B-cell receptor signaling pathway and apoptosis. Here, NFKB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.